Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
T cell receptor beta variable 10-3 (TRBV10-3) is a protein segment that forms part of the variable domain of the T cell receptor (TCR) beta chain, which is expressed on the surface of T lymphocytes. TRBV10-3 participates in the adaptive immune response by enabling T cells to recognize antigenic peptides presented by major histocompatibility complex (MHC) molecules on antigen-presenting cells. The TCR, consisting of alpha and beta chains, initiates signaling cascades that lead to T cell activation and immune function. TRBV10-3 is one of many variable regions generated through somatic recombination, contributing to the enormous diversity of antigen recognition by T cells. It is not itself a druggable target but plays a fundamental role in immune surveillance and can be involved in immune monitoring, immunotherapy, and disease pathogenesis when certain T cell clones expand abnormally[1][2][4][7][8].
Adoptive transfer of T cells engineered to express TCRs; Redirection of T cell specificity for therapeutic immune responses; Immunotherapy targeting TCR variants (in general, not specific to TRBV10-3)[6]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on T cell receptor beta variable 10-3 (TRBV10-3).